R. Knecht

发表

Reduction of cisplatin dosage by ZD 1839.

M. Hambek, M. Baghi, K. Strebhardt, 2005, Anticancer research.

Bone Ablation without Thermal or Acoustic Mechanical Injury via a Novel Picosecond Infrared Laser (PIRL)

Arne Böttcher, Wolfgang Wöllmer, Paul W Wiseman, 2014, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Patient-based cross-platform comparison of oligonucleotide microarray expression profiles

Grischa Toedt, Peter Lichter, Meinhard Hahn, 2005, Laboratory Investigation.

In vivo proton MR spectroscopy of primary tumours, nodal and recurrent disease of the extracranial head and neck

T. Vogl, W. Gstoettner, M. Baghi, 2006, European Radiology.

The efficacy of MRI with ultrasmall superparamagnetic iron oxide particles (USPIO) in head and neck cancers.

M. Mack, T. Vogl, W. Gstoettner, 2005, Anticancer research.

K. Rothkamm, R. Knecht, Katharina Krüger, 2016, Oncotarget.

Measurement and comparison of labyrinthine structures with the digital volume tomography: ancient Egyptian mummies’ versus today’s temporal bones

R. Knecht, U. Grzyska, C. Dalchow, 2013, European Archives of Oto-Rhino-Laryngology.

Circulating tumor cells in head and neck cancer: clinical impact in diagnosis and follow-up

K. Pantel, R. Knecht, S. Laban, 2013, European Archives of Oto-Rhino-Laryngology.

Current treatment options for recurrent/metastatic head and neck cancer: a post-ASCO 2011 update and review of last year’s literature

R. Knecht, S. Laban, N. Möckelmann, 2012, European Archives of Oto-Rhino-Laryngology.

Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells

Valérie Gailus-Durner, Bertolt Kreft, Martin Klingenspor, 2011, Nature communications.

Quantitative chemical proteomics reveals a Plk1 inhibitor-compromised cell death pathway in human cells

B. Kuster, Fiona Pachl, K. Strebhardt, 2014, Cell Research.

Cancer inhibition in nude mice after systemic application of U6 promoter-driven short hairpin RNAs against PLK1.

K. Strebhardt, R. Knecht, M. Kaufmann, 2004, Journal of the National Cancer Institute.

Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells

S. Loibl, K. Strebhardt, R. Knecht, 2002, Oncogene.

Molecular targeting agents in the context of primary chemoradiation strategies

S. Tribius, R. Knecht, S. Laban, 2013, Head & neck.

State of the art in the treatment of laryngeal cancer.

R. Knecht, F. Jenckel, Friederike Jenckel, 2013, Anticancer research.

Effect of sorafenib on cisplatin-based chemoradiation in head and neck cancer cells

R. Grenman, K. Rothkamm, R. Knecht, 2016, Oncotarget.

First results of Endonasal dilatation of the Eustachian tube (EET) in patients with chronic obstructive tube dysfunction

R. Knecht, C. Dalchow, F. Jenckel, 2016, European Archives of Oto-Rhino-Laryngology.

Usefulness of MRI volumetric evaluation in patients with squamous cell cancer of the head and neck treated with neoadjuvant chemotherapy

M. Mack, T. Vogl, W. Gstoettner, 2007, Head & neck.

Geographical and anatomical influences on human papillomavirus prevalence diversity in head and neck squamous cell carcinoma in Germany.

F. Hoppe, S. Tribius, R. Knecht, 2015, International journal of oncology.

The current role of systemic chemotherapy in the primary treatment of head and neck cancer.

S. Tribius, R. Knecht, P. Schafhausen, 2015, Cancer treatment reviews.

Human papilloma virus in locally advanced stage III/IV squamous cell cancer of the oropharynx and impact on choice of therapy.

S. Tribius, R. Knecht, C. Petersen, 2010, Oral oncology.

Postoperative antibiotic prophylaxis in clean-contaminated head and neck oncologic surgery: a retrospective cohort study

R. Knecht, C. Dalchow, B. Lörincz, 2016, European Archives of Oto-Rhino-Laryngology.

Cetuximab in the Treatment of Locally Advanced Head and Neck Cancer

R. Knecht, 2011 .

Prognostic relevance of volumetric analysis in tumour specimens of hypopharyngeal cancer

K. Engels, M. Hambek, M. Baghi, 2007, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

The inhibition of PARP but not EGFR results in the radiosensitization of HPV/p16-positive HNSCC cell lines.

R. Knecht, E. Dikomey, M. Kriegs, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[Radiotherapy, chemotherapy and target therapy for treatment of head and neck cancer : new developments].

R. Knecht, 2009, HNO.

Stable gene silencing of cyclin B1 in tumor cells increases susceptibility to taxol and leads to growth arrest in vivo

J. Yuan, K. Strebhardt, R. Knecht, 2006, Oncogene.

Inverse correlation between serum PGE2 and T classification in head and neck cancer

M. Hambek, M. Baghi, Helena Baumann, 2007, Head & neck.

Improvement of radiation treatment planning in squamous-cell head and neck cancer by immuno-SPECT.

S. Tieku, G. Hör, H. Böttcher, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Inventory of economic evaluation of head and neck oncology from the German perspective

R. Knecht, T. Kurzweg, 2014, European Archives of Oto-Rhino-Laryngology.

Standard or split TPF induction chemotherapy followed by bioradiation: ICRAT randomized phase II study.

V. Budach, I. Tinhofer, S. Tribius, 2016 .

Can prophylactic application of immunoglobulin decrease radiotherapy-induced oral mucositis?

H. Böttcher, C. Thilmann, R. Knecht, 1997, American journal of clinical oncology.

[Immunoglobulin for prevention of radiogenic mucositis].

H. Böttcher, C. Thilmann, R. Knecht, 1995, HNO.

Pituitary tumor-transforming gene expression is a prognostic marker for tumor recurrence in squamous cell carcinoma of the head and neck

R. Knecht, M. Roller, C. Solbach, 2006, BMC Cancer.

Enhancement of docetaxel efficacy in head and neck cancer treatment by G0 cell stimulation.

M. Hambek, M. Baghi, W. Gstöttner, 2005, European journal of cancer.

Laryngeal injuries following endotracheal intubation in ENT surgery: predictive value of anatomical scores

H. Pau, R. Knecht, S. Dommerich, 2014, European Archives of Oto-Rhino-Laryngology.

Palliative treatment standards for head and neck squamous cell carcinoma

R. Knecht, S. Laban, T. Hoffmann, 2016, HNO.

[Therapy of recurrent or metastatic head and neck squamous cell carcinoma : highlights of the ASCO Meeting 2014].

R. Knecht, P. Schafhausen, C. Busch, 2014, HNO.

Oncologic treatment landscape for head and neck squamous cell carcinoma

R. Knecht, S. Laban, T. Hoffmann, 2016, HNO.

New aspects of induction chemotherapy for head and neck cancer: POSTASCO 2011

R. Knecht, A. Mumme, S. Laban, 2012, European Archives of Oto-Rhino-Laryngology.

Antiproliferative activity of bortezomib alone and in combination with cisplatin or docetaxel in head and neck squamous cell carcinoma cell lines

H. Ackermann, M. Hambek, M. Baghi, 2008, Journal of Cancer Research and Clinical Oncology.

Enhanced podoplanin expression in chronic maxillary sinusitis.

R. Friedrich, R. Knecht, J. Zustin, 2013, In vivo.

Differentiation of benign and malignant parotid tumors using deconvolution-based perfusion CT imaging: feasibility of the method and initial results.

T. Vogl, C. Thng, M. Baghi, 2007, European journal of radiology.

Adjuvant docetaxel, cisplatin and 5-fluorouracil (TPF) in locally advanced squamous cell carcinoma of the head and neck.

W. Gstoettner, M. Hambek, M. Baghi, 2006, Anticancer Research.

A phase II trial of docetaxel, cisplatin and 5-fluorouracil in patients with recurrent squamous cell carcinoma of the head and neck (SCCHN).

W. Gstoettner, M. Hambek, M. Baghi, 2006, Anticancer research.

Demands on Caring Relatives of Head and Neck Cancer Patients

W. Gstoettner, M. Hambek, M. Baghi, 2007, The Laryngoscope.

Modulation of tamoxifen-induced apoptosis by peripheral benzodiazepine receptor ligands in breast cancer cells.

R. Knecht, M. Roller, N. Sänger, 2002, Biochemical pharmacology.

PLK (polo‐like kinase), a new prognostic marker for oropharyngeal carcinomas

K. Strebhardt, R. Knecht, K. Strebhardt, 2000, International journal of cancer.

Induction chemotherapy followed by radiochemotherapy for locally advanced head and neck cancer as an individual treatment approach—Feasibility, safety and retrospective survival analysis in twenty‐three patients

S. Tribius, R. Knecht, B. Lörincz, 2017, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

[The most important results on primary chemoradiation for head and neck squamous cell carcinoma: highlights from the 2012 ASCO meeting].

S. Tribius, R. Knecht, S. Laban, 2012, HNO.

[Is (chemo)radiotherapy really the future standard in the treatment of oropharyngeal carcinoma?].

R. Knecht, B. Lörincz, N. Möckelmann, 2016, HNO.

Current concepts of organ preservation in head and neck cancer

R. Knecht, C.-J. Wang, 2011, European Archives of Oto-Rhino-Laryngology.

TORS for head and neck squamous cell carcinoma (HNSCC): the Hamburg experience.

R. Knecht, B. Lörincz, 2015, B-ENT.

A comparison of hearing results following stapedotomy under local versus general anesthesia

R. Knecht, N. Jowett, C. Dalchow, 2015, European Archives of Oto-Rhino-Laryngology.

Heat generation during ablation of porcine skin with erbium:YAG laser vs a novel picosecond infrared laser.

R. Knecht, B. Segal, P. Wiseman, 2013, JAMA otolaryngology-- head & neck surgery.

Locally Advanced Squamous Cell Cancer of the Head and Neck — Targeting Epidermal Growth Factor Receptor

R. Knecht, 2007 .

Tumor Necrosis Factor a Sensitizes Low Epidermal Growth Factor Receptor ( EGFR )-expressing Carcinomas for Anti-EGFR Therapy 1

M. Hambek, R. Knecht, M. Roller, 2001 .

Prestimulation of head and neck cancer cells with growth factors enhances treatment efficacy.

M. Hambek, M. Baghi, W. Gstöttner, 2006, Anticancer research.

AdOnco: A Database for Clinical and Scientific Documentation of Head and Neck Oncology

W. Gstoettner, M. Hambek, M. Baghi, 2006, The Annals of otology, rhinology, and laryngology.

Cancer of the uterine cervix is susceptible to anti-EGF-R antibody EMD 55,900 therapy.

R. Knecht, M. Kaufmann, M. Roller, 2005, Anticancer research.

Epidermal growth factor receptor (EGFR) in salivary gland carcinomas: potentials as therapeutic target.

G. Sauter, C. Bokemeyer, T. Clauditz, 2012, Oral oncology.

Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas

G. Sauter, C. Bokemeyer, T. Clauditz, 2011, Pathology.

Imaging of ancient Egyptian mummies’ temporal bones with digital volume tomography

R. Knecht, U. Grzyska, C. Dalchow, 2012, European Archives of Oto-Rhino-Laryngology.

Facial mimetic, cosmetic, and functional standardized assessment of the facial artery musculomucosal (FAMM) flap.

T. Hadlock, R. Knecht, E. Sela, 2017, Auris, nasus, larynx.

The endoscopic approach to the Neck: A review of the literature, and overview of the various techniques

R. Knecht, C. Dalchow, A. Muenscher, 2011, Surgical Endoscopy.

A novel technetium-99m labeled monoclonal antibody (174H.64) for staging head and neck cancer by immuno-SPECT.

R. Knecht, R. Baum, H. Howaldt, 1993, Acta oncologica.

11q21 Rearrangement is a Frequent and Highly Specific Genetic Alteration in Mucoepidermoid Carcinoma

G. Sauter, T. Clauditz, W. Wilczak, 2012, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Sequential Cdk1 and Plk1 phosphorylation of caspase‐8 triggers apoptotic cell death during mitosis

K. Strebhardt, R. Knecht, Y. Matthess, 2014, Molecular oncology.

Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck.

G. Sauter, T. Clauditz, W. Wilczak, 2013, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

Cetuximab Resistance in Head and Neck Cancer Is Mediated by EGFR-K521 Polymorphism.

C. Bokemeyer, T. Grob, Anja Thalhammer, 2017, Cancer research.

A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neck

J. Machiels, T. Gauler, S. Braun, 2015, Cancer Chemotherapy and Pharmacology.

Sorafenib sensitizes head and neck squamous cell carcinoma cells to ionizing radiation.

T. Grob, R. Knecht, E. Dikomey, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy.

A. Schueler, R. Knecht, R. Hitt, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Role of panendoscopy in identifying and managing risk of head and neck squamous cell carcinoma in routine follow-up: a retrospective clinical evaluation

T. Clauditz, S. Tribius, R. Knecht, 2015, European Archives of Oto-Rhino-Laryngology.

Abundant expression of mTOR kinase in salivary gland tumors - potentials as therapy target?

G. Sauter, C. Bokemeyer, T. Clauditz, 2013, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

Continuous tissue microarray based identification of cancers with homogeneous target expression for successful targeted therapy in clinical routine practice

G. Sauter, C. Bokemeyer, T. Clauditz, 2014, Genes, chromosomes & cancer.

Prognostic significance of polo-like kinase (PLK) expression in squamous cell carcinomas of the head and neck.

C. von Ilberg, K. Strebhardt, R. Knecht, 1999, Cancer research.

Automatic periodic stimulation of the vagus nerve during single‐incision transaxillary robotic thyroidectomy: Feasibility, safety, and first cases

R. Knecht, B. Lörincz, C. Busch, 2016, Head & neck.

pERK 1/2 inhibit Caspase‐8 induced apoptosis in cancer cells by phosphorylating it in a cell cycle specific manner

K. Strebhardt, R. Knecht, Y. Matthess, 2014, Molecular oncology.

High‐level &bgr;III‐tubulin overexpression occurs in most head and neck cancers but is unrelated to clinical outcome

G. Sauter, T. Clauditz, R. Simon, 2017, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

CD151 expression is frequent but unrelated to clinical outcome in head and neck cancer

G. Sauter, T. Clauditz, R. Simon, 2016, Clinical Oral Investigations.

Molecular targeting in combination with platinum‐based chemoradiotherapy in head and neck cancer treatment

R. Knecht, M. Kriegs, B. Lörincz, 2016, Head & neck.

Pituitary tumor-transforming gene (PTTG): a novel target for anti-tumor therapy.

R. Knecht, M. Kaufmann, M. Nicoletti, 2005, Anticancer research.

Initial learning curve of single-incision transaxillary robotic hemi- and total thyroidectomy--A single team experience from Europe.

R. Knecht, B. Lörincz, C. Busch, 2015, International journal of surgery.

Single-incision transaxillary robotic total thyroidectomy for Graves’ disease: improved feasibility and safety with novel robotic instrumentation

R. Knecht, B. Lörincz, N. Möckelmann, 2014, European Archives of Oto-Rhino-Laryngology.

Radiographic regression of vestibular schwannomas induced by bevacizumab treatment: sustain under continuous drug application and rebound after drug discontinuation.

C. Bokemeyer, V. Mautner, R. Knecht, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

TPF induction chemotherapy followed by concurrent radiochemotherapy in the first line therapy of advanced carcinomas of the larynx and pharynx (phase IIb trial).

H. Tesch, M. Hambek, M. Baghi, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Simultaneous cytoplasmic and nuclear protein expression of melanoma antigen‐A family and NY‐ESO‐1 cancer‐testis antigens represents an independent marker for poor survival in head and neck cancer

G. Sauter, T. Luetkens, D. Atanackovic, 2014, International journal of cancer.

New treatment strategies for HPV-positive head and neck cancer

R. Knecht, S. Laban, B. Lörincz, 2014, European Archives of Oto-Rhino-Laryngology.

Tumor necrosis factor alpha sensitizes low epidermal growth factor receptor (EGFR)-expressing carcinomas for anti-EGFR therapy.

M. Hambek, R. Knecht, M. Roller, 2001, Cancer research.

Direct quantification of polo-like kinase 1 activity in cells and tissues using a highly sensitive and specific ELISA assay

Joobae Park, Kyung S. Lee, Luowei Li, 2009, Proceedings of the National Academy of Sciences.

The impact of surgical technique on neck dissection nodal yield: making a difference

R. Knecht, S. Sehner, B. Lörincz, 2016, European Archives of Oto-Rhino-Laryngology.

[Overview of Alternative Methods of Cochleostomy with Focus on Laser Ablative Techniques].

R. Knecht, C. Dalchow, A. Böttcher, 2015, Laryngo- rhino- otologie.

Primary B cell lymphoma of the sphenoid sinus: CT and MRI characteristics with correlation to perfusion and spectroscopic imaging features

T. Vogl, A. Feller, W. Gstoettner, 2007, European Archives of Oto-Rhino-Laryngology.

Endonasal dilatation of the Eustachian tube (EET) in children: feasibility and the role of tubomanometry (Estève) in outcomes measurement

R. Knecht, C. Dalchow, B. Lörincz, 2015, European Archives of Oto-Rhino-Laryngology.

Radiographic examination of patients with dehiscence of semicircular canals with digital volume tomography

R. Knecht, U. Grzyska, A. Muenscher, 2013, European Archives of Oto-Rhino-Laryngology.

Functional outcomes, feasibility, and safety of resection of transoral robotic surgery: Single‐institution series of 35 consecutive cases of transoral robotic surgery for oropharyngeal squamous cell carcinoma

R. Knecht, B. Lörincz, C. Busch, 2015, Head & neck.

Two-Year Survival Analysis of 50 Consecutive Head and Neck Cancer Patients Treated with Transoral Robotic Surgery in a Single European Centre

R. Knecht, S. Sehner, C. Dalchow, 2015, Annals of Surgical Oncology.

Strategies to promote translational research within the European Organisation for Research and Treatment of Cancer (EORTC) Head and Neck Cancer Group: a report from the Translational Research Subcommittee

D. Lacombe, J. B. Vermorken, J. A. Langendijk, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Antitumor effect of MAb EMD 55900 depends on EGF-R expression and histopathology.

R. Knecht, M. Kaufmann, M. Roller, 2002, Neoplasia.

Endpoints and cutpoints in head and neck oncology trials: methodical background, challenges, current practice and perspectives

R. Knecht, B. Lörincz, T. Kurzweg, 2016, European Archives of Oto-Rhino-Laryngology.

Gene expression profiling of circulating natural killer cells in head and neck squamous cell carcinoma.

R. Knecht, J. Ostwald, D. Koczan, 2013, Cancer genomics & proteomics.

Robotic-assisted selective and modified radical neck dissection in head and neck cancer patients.

R. Knecht, B. Lörincz, N. Möckelmann, 2016, International journal of surgery.

Curative treatment of head and neck squamous cell carcinoma

R. Knecht, P. Schuler, S. Laban, 2016, HNO.

Liquid biopsy monitoring uncovers acquired RAS-mediated resistance to cetuximab in a substantial proportion of patients with head and neck squamous cell carcinoma

C. Bokemeyer, T. Grob, R. Knecht, 2016, Oncotarget.

Decision management in transoral robotic surgery: Indications, individual patient selection, and role in the multidisciplinary treatment for head and neck cancer from a European perspective

R. Knecht, N. Jowett, B. Lörincz, 2016, Head & neck.

EGFRK 521 mediates resistance to Cetuximab in head and neck cancer

C. Bokemeyer, T. Grob, Anja Thalhammer, 2016 .

Timing of neck dissection in patients undergoing transoral robotic surgery for head and neck cancer.

R. Knecht, B. Lörincz, C. Busch, 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Feasibility and safety of transoral robotic surgery (TORS) for early hypopharyngeal cancer: a subset analysis of the Hamburg University TORS-trial

R. Knecht, B. Lörincz, C. Busch, 2015, European Archives of Oto-Rhino-Laryngology.

[Transoral robotic total laryngectomy and neck dissection: the concept of robotic combo surgery].

R. Knecht, B. Lörincz, 2013, Laryngo- rhino- otologie.

[The development of TORS in Europe].

R. Knecht, S. Laban, B. Lörincz, 2013, HNO.

Iron oxide particle-enhanced magnetic resonance imaging for detection of benign lymph nodes in the head and neck: how reliable are the results?

M. Mack, T. Vogl, W. Gstoettner, 2007, Anticancer research.

Reduction of thermocoagulative injury via use of a picosecond infrared laser (PIRL) in laryngeal tissues

R. Knecht, U. Schumacher, S. Anders, 2015, European Archives of Oto-Rhino-Laryngology.

Use of a microsecond Er:YAG laser in laryngeal surgery reduces collateral thermal injury in comparison to superpulsed CO2 laser

Arne Böttcher, Wolfgang Wöllmer, R. Knecht, 2014, European Archives of Oto-Rhino-Laryngology.

Comparative study of wound healing in rat skin following incision with a novel picosecond infrared laser (PIRL) and different surgical modalities

M. Kwiatkowski, W. D. Robertson, H. Schlüter, 2016, Lasers in surgery and medicine.

A novel tool in laryngeal surgery: Preliminary results of the picosecond infrared laser

T. Clauditz, W. Wilczak, R. Knecht, 2013, The Laryngoscope.

Cetuximab monotherapy is active in patients (pts) with platinum-refractory recurrent/metastatic squamous cell carcinoma of the head and neck (SCCHN): Results of a phase II study.

J. Baselga, R. Knecht, R. Hitt, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

STAT 3 activation in head and neck squamous cell carcinomas is controlled by the EGFR.

M. Hambek, M. Baghi, K. Strebhardt, 2004, Anticancer research.

The antileukoprotease secretory leukocyte protease inhibitor (SLPI) and its role in the prevention of HPV-infections in head and neck squamous cell carcinoma.

F. Hoppe, R. Knecht, C. Röcken, 2015, Cancer letters.

Activated leukocyte cell adhesion molecule (ALCAM/CD166) expression in head and neck squamous cell carcinoma (HNSSC).

G. Sauter, T. Clauditz, W. Wilczak, 2014, Pathology, research and practice.

Quantitative Measurements of Perfusion and Permeability of Oropharyngeal and Oral Cavity Cancer, Recurrent Disease, and Associated Lymph Nodes Using First-Pass Contrast-Enhanced Computed Tomography Studies

Thomas Lehnert, Sotirios Bisdas, Tong San Koh, 2007, Investigative radiology.

Iressa (ZD 1839) inhibits phosphorylation of three different downstream signal transducers in head and neck cancer (SCCHN).

M. Hambek, M. Baghi, K. Strebhardt, 2005, Anticancer research.

Response rate and outcome of a novel first line therapy for advanced head and neck carcinomas: Chemo-radiochemotherapy (CRC)

H. Tesch, M. Hambek, M. Baghi, 2004 .

Response rate and outcome of a novel first line therapy for advanced head and neck carcinomas: Chemo-radiochemotherapy (CRC).

H. Tesch, M. Hambek, M. Baghi, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Perspectives in chemosensitivity and chemoresistance assays and their implementation in head and neck cancer

R. Knecht, B. Lörincz, C. Busch, 2016, European Archives of Oto-Rhino-Laryngology.

[Tumor-associated macrophages (TAM) in the stroma of squamous cell carcinomas of the ENT area studied using monoclonal antibodies].

C. von Ilberg, R. Knecht, R. Bettinger, 1990, Laryngo- rhino- otologie.

Larynx Preservation in Head and Neck Cancer

M. Mack, W. Gstoettner, M. Hambek, 2005 .

HPV-positive HNSCC cell lines but not primary human fibroblasts are radiosensitized by the inhibition of Chk1.

S. Tribius, R. Knecht, E. Dikomey, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[New aspects in the treatment of thyroid cancer : Highlights of the ASCO Annual Meeting 2016].

R. Knecht, B. Lörincz, N. Möckelmann, 2016, HNO.

Cetuximab enhances the efficacy of bortezomib in squamous cell carcinoma cell lines

H. Ackermann, M. Hambek, M. Baghi, 2009, Journal of Cancer Research and Clinical Oncology.

Anti‐epidermal growth factor receptor‐antibody therapy for treatment of breast cancer

S. Loibl, A. Ahr, R. Knecht, 2002, International journal of cancer.

CD151 expression is frequent but unrelated to clinical outcome in head and neck cancer

G. Sauter, T. Clauditz, R. Simon, 2017, Clinical Oral Investigations.

Investigation of noise levels generated by otologic drills

R. Knecht, C. Dalchow, F. Kameier, 2013, European Archives of Oto-Rhino-Laryngology.

Effect of bortezomib and cetuximab in EGF-stimulated HNSCC.

H. Ackermann, M. Hambek, M. Baghi, 2008, Anticancer research.

Effect of bortezomib on EGFR expression in head and neck squamous cell carcinoma cell lines.

M. Hambek, M. Baghi, R. Knecht, 2008, Anticancer research.

Stellenwert neuer Behandlungsansätze mit Targettherapeutika bei malignen Schilddrüsenerkrankungen

R. Knecht, S. Laban, F. Uecker, 2012, HNO.

Extent of Lateral Neck Dissection in Differentiated Thyroid Carcinoma.

R. Knecht, B. Lörincz, 2015, Deutsches Arzteblatt international.

Sym004, a novel strategy to target EGFR with an antibody mixture, in patients with advanced SCCHN progressing after anti-EGFR monoclonal antibody: A proof of concept study.

J. Machiels, T. Gauler, A. Dietz, 2013 .

EGFR antibody-supplemented TPE-chemotherapy. Preclinical investigations to a novel approach for head and neck cancer induction treatment.

M. Hambek, M. Baghi, W. Gstöttner, 2003, Anticancer research.